Stay Informed on Corporate Sustainability

Author: PT

Eli Lilly will increase the UK list price of Mounjaro (tirzepatide) from £92–£122 to £133–£330 per month starting 1 September.

Author: Irish Independent

Eli Lilly and Johnson & Johnson have highlighted risks to Ireland’s pharmaceutical sector as US trade uncertainties grow. Companies warned that EU regulations, supply chain vulnerabilities, and a need for a skilled workforce could impact Ireland’s position as a life sciences hub.

Author: EPR

WuXi Biologics’ Dundalk facility has received European Medicines Agency approval to begin commercial production of a global client’s innovative biologic.

Author: April Lara

This week reminds us that progress in pharmaceuticals comes in many forms.

Author: April Lara

Navigate Brazil’s ANVISA regulations with SGS expertise for faster approvals, reduced risk and smooth market entry.

Author: April Lara

Entering the Pharma Industry Awards 2025 is about more than recognition—it’s a chance to show how your organisation is shaping the future of healthcare.

Author: STAT

Pfizer’s antibody-drug conjugate Padcev, paired with Keytruda, has shown a survival benefit for patients with invasive bladder cancer who cannot undergo cisplatin chemotherapy.

Author: Business Mirror

Novo Nordisk has teamed up with telehealth provider ORA to deliver fully digital, end-to-end obesity care in the Philippines.

Author: Pharmalive

Insmed’s Brinsupri has secured US FDA approval as the first therapy for non-cystic fibrosis bronchiectasis, offering targeted anti-inflammatory action without antibiotics.

Author: Irish Independent

Donald Trump’s warning of up to 250% tariffs on European pharmaceutical exports has thrown fresh uncertainty into Ireland’s most valuable sector.